An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Recruiting · NCT06401356 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Extension Study for Patients Previously Enrolled in Studies With Pelabresib | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 3 | 2026-06-11 | NCT06401356 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic Jacksonville | Jacksonville | United States | 67 |
| Mt Sinai Medical Center | New York | United States | 2 |
| New York Presbyterian Hospital | New York | United States | 4 |
| Northwestern University | Chicago | United States | 727 |
| Uni Of Michigan Health System | Ann Arbor | United States | 5 |
| University of California LA | Los Angeles | United States | 12 |